InsidersTradesSigma
申报总数
公司
▲ 买入（0 笔）
▼ 卖出（0 笔）
内部人交易记录
首席财务官已披露买入
0
已披露卖出
0
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
信号历史
Browse the full record of transactions filed by Harvey Brian Nicholas, 首席财务官. Officer active across 1 company, notably Adicet Bio, Inc.. Aggregated, 10 reports have been published. History available since 1 October 2021. The latest transaction was filed on 24 January 2026 (Retenue fiscale). Regulator: SEC (Form 4). All data is openly available.
Companies and markets linked to Harvey Brian Nicholas
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报10 总计
546 股@ US$8.443.0% 占其流量Common StockSEC:0001193125-26-024746:0
8,752 股@ US$0.92185.9% 占其流量Common StockSEC:0000950170-25-009827:0
4,320 股@ US$2.407.3% 占其流量Common StockSEC:0000950170-24-008048:0
7,096 股@ US$1.377.1% 占其流量Common StockSEC:0001209191-23-051468:0
26,100 股0Common StockSEC:0001209191-23-005043:0
7,096 股@ US$14.2276.8% 占其流量Common StockSEC:0001209191-22-052380:0
16,000 股0Common StockSEC:0001209191-22-044902:0
16,000 股0Common StockSEC:0001209191-22-010479:0
16,000 股0Common StockSEC:0001209191-22-006134:0
80,000 股0Common StockSEC:0001209191-21-059569:0
10 条申报中的 10 条
About Harvey Brian Nicholas
Harvey Brian Nicholas is Directeur Financier at Adicet Bio, Inc. He has 10 filings in total, and across the 10 sampled filings the most common transaction nature is Tax withholding, with buy and sell amounts of EUR 0 each, over the period from 2021-10-05 to 2026-01-27.
